Scale Up and Boost Your Viral Vector Production

Cellevate CEO discusses scale up and boost viral vector production needs for biotech and partnerships at BIO-Europe 2024

BIO-Europe 2024

December 17, 2024

4 Min View
@Informa Life Sciences

Laura Chirica, CEO of Cellevate walks through the company’s recent launch of its nanofiber-based cell culture systems starter pack. Cellevate is coming to the bioprocessing industry with a disruptive technology that offers 60% more surface area for cells to grow, according to the company. The company’s vision is be a part of accelerating the biomanufacturing revolution.

Read more about:

BioprocessingEBD Events
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.